Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies

Details for Australian Patent Application No. 2006233216 (hide)

Owner Allergan, Inc. The Trustees of the University of Pennsylvania

Inventors Not Given

Agent Davies Collison Cave

Pub. Number AU-A-2006233216

Parent 2001255488

Filing date 27 October 2006

Wipo publication date 16 November 2006

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/19 (2006.01)

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

Event Publications

9 November 2006 Complete Application Filed

16 November 2006 Application Open to Public Inspection

  Published as AU-A-2006233216

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006233217-Cableway having devices for conveying persons

2006233215-Method for self-synchronizing a conveyor belt sensor system